Screening for atrial fibrillation: a report of the AF-SCREEN international collaboration

B Freedman, J Camm, H Calkins, JS Healey… - Circulation, 2017 - Am Heart Assoc
Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first
diagnosed at the time of stroke. Detecting asymptomatic AF would provide an opportunity to …

[HTML][HTML] Diabetes mellitus and heart failure

M Lehrke, N Marx - The American journal of cardiology, 2017 - Elsevier
Epidemiologic and clinical data from the last 2 decades have shown that the prevalence of
heart failure in diabetes is very high, and the prognosis for patients with heart failure is …

[PDF][PDF] 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

V Aboyans, JB Ricco, ML Bartelink… - Kardiologia Polska …, 2017 - journals.viamedica.pl
W 2011 roku ESC opublikowało pierwsze wytyczne dotyczące rozpoznawania i leczenia
chorób tętnic obwodowych (PAD)[1]. Ta publikacja wypełniła ważną lukę wśród wytycznych …

[HTML][HTML] Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation

CP Cannon, DL Bhatt, J Oldgren, GYH Lip… - … England Journal of …, 2017 - Mass Medical Soc
Background Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the
standard of care after percutaneous coronary intervention (PCI) for patients with atrial …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study

JPJ Halcox, K Wareham, A Cardew, M Gilmore… - Circulation, 2017 - Am Heart Assoc
Background: Asymptomatic atrial fibrillation (AF) is increasingly common in the aging
population and implicated in many ischemic strokes. Earlier identification of AF with …

Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study

S Prabhu, AJ Taylor, BT Costello, DM Kaye… - Journal of the American …, 2017 - jacc.org
Background: Atrial fibrillation (AF) and left ventricular systolic dysfunction (LVSD) frequently
co-exist despite adequate rate control. Existing randomized studies of AF and LVSD of …

Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT

IC Van Gelder, JS Healey, HJGM Crijns… - European heart …, 2017 - academic.oup.com
Background ASSERT demonstrated that subclinical atrial fibrillation (SCAF) is common in
pacemaker patients without prior AF and is associated with increased risk of ischemic stroke …

[HTML][HTML] Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation

H Calkins, S Willems, EP Gerstenfeld… - … England Journal of …, 2017 - Mass Medical Soc
Background Catheter ablation of atrial fibrillation is typically performed with uninterrupted
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant …

[HTML][HTML] Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up …

LV Boersma, H Ince, S Kische, E Pokushalov… - Heart rhythm, 2017 - Elsevier
Background Left atrial appendage (LAA) occlusion with WATCHMAN has emerged as viable
alternative to vitamin K antagonists in randomized controlled trials. Objective EWOLUTION …